SIB 1893
Alternative Names: 2-Methyl-6-(phenylethenyl) pyridineLatest Information Update: 06 Apr 2010
At a glance
- Originator Merck & Co
- Class Antiepileptic drugs; Neuroprotectants
- Mechanism of Action Metabotropic glutamate receptor 5 antagonists; NMDA receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Neurological disorders
Most Recent Events
- 06 Apr 2010 No development reported - Preclinical for Neurological disorders (Prevention) in USA (unspecified route)
- 20 Aug 2002 This compound is still in active development
- 11 Dec 2000 Preclinical development for Neurological disorders (Prevention) in USA (Unknown route)